Some doctors are cautious about GLP-1 medications for valid clinical reasons, and some are simply unfamiliar with the newer options
A significant interaction between group and time ( 2 (7) = 18.86, p = 0.009, f = 0.39) was found in the linear mixed effects model, revealing that the GLP-1RA group consistently rated their intoxication lower across multiple timepoints compared to the control group (Fig
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: A meta-analysis and meta-regression analysis
M.TheinP.ParsaA.YorgasonJ.LuxfordW.UrrutiaR.et al (2014)
En este subanlisis, semaglutida demostr beneficios renales en personas con obesidad y riesgo cardiovascular alto, pero sin DM2, reduciendo de manera significativa los eventos adversos renales (semaglutida [1,8%] frente a placebo [2,2%]) y desacelerando la cada del filtrado glomerular (semaglutida 0,78 frente a placebo 1,17ml/min/1,73m2/ao)
When theyre out of balance, everything feels harder